{
  "document_id": "HOUSE_OVERSIGHT_024104",
  "filename": "IMAGES-007-HOUSE_OVERSIGHT_024104.txt",
  "text": "Sprout Capital VIL, L.P. (Healthcare Technology Portfolio)\n\n$ amounts in millions, as of March 31, 2014\nPlease refer to Endnotes 1,],K,L,M and N in this Appendix.\n\nGross\nMultiple Gross\nVintage Total Realized Unrealize Total (Realized Multiple\n\nCompany Year Cost Value d Value Value Portion) (Total) Gross IRR\nAdeza Biomedical Corporation Diagnostics & Infrastructure 1996 4.8 27.7 - 27.7 5.75 5.75 20.1%\nAllos Therapeutics, Inc. Therapeutics 1998 2.6 wD - 7.5 2.87 2.87 38.8%\nAradigm Corporation Therapeutics 1994 2.8 15.3 - 15.3 5.45 5.45 39.3%\nAtheroGenics, Inc. Therapeutics 1996 3:8 7.1 - 7.1 1.87 1.87 13.7%\nAviaHealth, Inc. (fka GoToMyDoc) Convergence 2000 1.6 0.0 - 0.0 0.02 0.02 -92.8%\nCombiChem, Inc. Therapeutics 1995 3.9 9.4 - 94 2.43 2.43 26.5%\nConnetics Corp. (fka Connective) Therapeutics 1995 6.3 14.2 - 14.2 2.24 2.24 15.5%\nFemRX Healthcare Devices 1995 2.2 3.2 - 3.2 1.47 1.47 11.6%\nHealtheon/ WebMD (Sapient) Convergence 1996 3.0 39.8 - 39.8 13.42 13.42 190.1%\nHearten Medical Healthcare Devices 1997 1.7 - - - - - NM\nIntraBiotics Pharmaceuticals Therapeutics 1994 3.9 7.3 - 7.3 1.89 1.89 13.4%\nLynx Therapeutics, Inc. Diagnostics & Infrastructure 1995 1.1 2.9 - 2.9 DPD: 2.72 25.4%\nNxStage Medical, Inc. Healthcare Devices 2003 B8 18.9 - 18.9 5.80 5.80 20.9%\nOrquest, Inc. Healthcare Devices 1995 5.5 78 - 7.8 1.42 1.42 6.1%\nPathology Partners Diagnostics & Infrastructure 1997 3.3 22.4 - 22.4 6.82 6.82 38.2%\nPharsight Corporation Convergence 1997 4.9 7.3 - 7.3 148 148 6.0%\nPoint Biomedical Diagnostics & Infrastructure 1997 9.2 0.0 - 0.0 0.00 0.00 NM\nPrometheus Laboratories, Inc. Therapeutics 1998 7.8 38.8 - 38.8 5.00 5.00 13.4%\nSalient Interventional Systems Healthcare Devices 1998 27 0.0 - 0.0 0.00 0.00 NM\nSkila, Inc. Convergence 1998 5.2 0.2 - 0.2 0.05 0.05 NM\nTriPath Imaging, Inc. Diagnostics & Infrastructure 1996 4.9 13.9 - 13.9 2.83 2.83 17.2%\nVascA, Inc. Healthcare Devices 1996 6.5 0.1 - 0.1 0.02 0.02 NM\nVNUS Medical Technologies, Inc. Healthcare Devices 1997 4.3 15.7 - 15.7 3.66 3.66 12.1%\nXcyte Therapies, Inc. (CDR) Therapeutics 1996 6.1 0.5 - 0.5 0.08 0.08 -33.6%\nTotal Sprout Capital VIL, L.P. (HCT) Investments $ 101.2 $ 260.0 $ - $ 260.0 2.57, 2.57 18.6%\n\nSprout Growth IL L.P. (Healthcare Technology Portfolio)\n\n$ amounts in millions, as of March 31, 2014\nPlease refer to Endnotes 1,J,K,L,M and N in this Appendix.\n\nGross\n\nMultiple Gross\n\nVintage Total Realized Unrealize Total (Realized Multiple\nCompany Sector Year Cost Value d Value Value Portion) (Total) Gross IRR\n\nAll Investments\n\nAdeza Biomedical Corporation Diagnostics & Infrastructure $ : $ $ $ 20.1%\nAviaHealth, Inc. (fka GoToMyDoc) Convergence 2000 $ 13 $ 0.0 $ - $ 0.0 0.02 0.02 -92.8%\nCephalon, Inc. Therapeutics 1999 $ 41 $ 20.5 $ - $ 20.5 5.01 5.01 293.2%\nConnetics Corp. (fka Connective) Therapeutics 1997 $ 3.2 §$ 65 §$ - $ 6.5 2.05 2.05 16.7%\nIVAC Holdings, Inc. Healthcare Devices 1995 $ 0.9 §$ 3.0 $ - $ 3.0 3.31 3.31 121.9%\nPathology Partners Diagnostics & Infrastructure 1997 $ 2.7 $ 18.3 $ - $ 18.3 6.82 6.82 38.1%\nTotal Sprout Growth II, L.P. (HCT) Investments $ 161 §$ 70.9 §$ - $ 70.9 4.42 4.42 43.8%\n93 CONTROL NUMBER 257 - CONFIDENTIAL\n\nHOUSE_OVERSIGHT_024104",
  "metadata": {
    "original_filename": "IMAGES-007-HOUSE_OVERSIGHT_024104.txt",
    "source_dataset": "huggingface:tensonaut/EPSTEIN_FILES_20K",
    "character_count": 3184,
    "word_count": 531,
    "line_count": 60,
    "import_date": "2025-11-19T21:47:49.256749",
    "prefix": "IMAGES-007"
  }
}